Human Health and Potential (HHP)

While the new Omicron XBB COVID-19 subvariant deftly dodges immune defences even in vaccinated individuals, researchers find that mixed mRNA vaccines may offer a vital boost of protection.

A new portable diagnostic technology promises unparalleled speed, accuracy and clinical utility for ovarian cancer diagnoses.

Researchers reveal how disrupting a key genetic control mechanism can significantly hinder the progression and spread of an aggressive and difficult-to-treat form of breast cancer.

A*STAR researchers identified the mechanism behind how a common gene mutation in kidney cancer impacts chromatin remodelling and drives tumour development, opening up new possibilities for therapeutic interventions.

A*STAR researchers tackle the challenge of creating therapeutic antibodies that effectively kill tumours and are also easily scalable in manufacturing settings.

A new computational tool accurately predicts RNA modifications from sequencing data, allowing researchers to study and develop novel therapies for complex diseases such as cancer.

A study reveals how age, SARS-CoV-2 variants and booster shots affect immune responses to the COVID-19 vaccine.

A new approach combines surface-enhanced Raman spectroscopy with advanced computer analysis to accurately and rapidly detect lung cancer by analysing fluid around the lungs.

A new deep learning method outperforms traditional methods for identifying genetic mutations from DNA sequences and can be a valuable tool for improved cancer diagnostics.

Despite an increased calorie intake, the consumption of unsaturated fats from Asian-based oil blends did not lead to significant changes in total body fat among Asian participants.

A non-invasive diagnostic method that uses light and sound can help clinicians assess and track patients with a chronic inflammatory skin condition.

Investigations into an under-explored region of SARS-CoV-2’s spike protein reveals detailed structural insights that can represent valuable drug targets.